Edit this postStocks to Watch on 28 October 2026: Key Market Updates
About This Stock Market Update
This article summarises the supplied corporate updates for 28 October 2026, covering quarterly results, revenue growth, EBITDA margins, order inflows, market share and business performance.
The stocks are grouped by the reported nature of their updates. Positive operating indicators do not automatically mean a stock will rise, while results below expectations do not necessarily guarantee a price decline.
Indian markets have several company-specific developments to track on 28 October 2026. The updates cover infrastructure, insurance, pharmaceuticals, automobiles, telecom, cement, food products, financial services and other sectors.
Investors should distinguish between reported financial performance, operational indicators and market expectations. Revenue growth and stronger margins can support business performance, but valuations, future guidance, debt, cash flow and the price already reflected in the stock also matter.
Key Stocks to Watch
🟢 L&T: Revenue rises 16%, while order inflows increase 27.5% year-on-year.
🟢 SBI Life: Q2 results are reported in line with estimates; VNB margin improves 130 basis points year-on-year.
🟢 United Breweries: Q2 revenue rises 24% year-on-year, with results reported above estimates.
🟢 Piramal Pharma: Q2 results are reported above estimates, with the highest margin since Q4 FY26.
🟢 Syngene International: Margin reaches 17.7% versus 12.3%, with net profit moving from a quarterly loss to a profit.
🟢 IndiGo: September market share increases to 65.4% from 65% in August.
🟢 Indus Towers: Margin improves by 80 basis points, while EBITDA rises 2.5% quarter-on-quarter.
🟢 LT Foods: EBITDA rises 9% and revenue increases 17% year-on-year.
🟢 Kirloskar Brothers: EBITDA increases 15% and revenue grows 24% year-on-year.
🟢 Tanla Platforms: EBITDA rises 20.8%, while revenue increases 25% year-on-year.
These updates offer a starting point for further research rather than a direct buy or sell recommendation. Investors should compare each company's performance with its own previous results, sector conditions and current valuation.
Company-Wise Market Updates
| Company | Reported Update | What to Monitor |
|---|---|---|
| L&T | Revenue up 16%; order inflows up 27.5% YoY. | Order execution, margins and future order pipeline. |
| SBI Life Insurance | Q2 in line with estimates; VNB margin up 130 bps YoY. | New business growth, product mix and persistency. |
| Max Financial Services | Q2 above estimates; total APE up 7% YoY. | Annualised premium growth and insurance business performance. |
| United Breweries | Q2 above estimates; revenue up 24% YoY. | Volume growth, realisations and input costs. |
| Tata Capital | Net interest income up 23%; net loans up 26.9% YoY. | Asset quality, funding costs and credit growth. |
| Piramal Pharma | Q2 above estimates; margin highest since Q4 FY26. | Margin sustainability, order pipeline and segment performance. |
| Syngene International | Margin at 17.7% versus 12.3%; net profit versus loss QoQ. | Revenue mix, project demand and repeatability of profit improvement. |
| PG Electroplast | Q2 above estimates; product business up 42% YoY. | Capacity utilisation, product mix and margins. |
| Home First Finance | AUM up 27%; disbursements rise 32% YoY. | Asset quality, cost of borrowing and loan growth. |
| MedPlus Health Services | Revenue up 21.3% YoY; margin at 8.3% versus 7.1% QoQ. | Store-level performance, operating costs and margin durability. |
| IndiGo | September market share at 65.4%, versus 65% in August. | Passenger demand, yields, capacity and operating costs. |
| Indus Towers | Margin up 80 bps; EBITDA rises 2.5% QoQ. | Tenancy additions, customer payments and cash flow. |
| JSW Cement | Q2 volumes at 3.93 million tonnes versus 3.11 million tonnes; revenue up 33% YoY. | Realisation per tonne, fuel costs and capacity utilisation. |
| LT Foods | EBITDA up 9%; revenue up 17% YoY. | Export demand, product mix and raw-material costs. |
| Raymond | EBITDA up 74%; margin rises 336 bps YoY. | Underlying segment growth and sustainability of margin expansion. |
| Kirloskar Brothers | EBITDA up 15%; revenue up 24% YoY. | Order execution, margins and working capital. |
| Gravita India | Q2 in line with estimates; revenue up 36% YoY. | Commodity spreads, operating margins and cash conversion. |
| PTC India Financial Services | Profit up 9.5%; net interest income up 2.5% YoY. | Loan quality, recoveries and net interest margin. |
| Tanla Platforms | EBITDA up 20.8%; revenue up 25% YoY. | Customer concentration, revenue quality and margins. |
| Route Mobile | Adjusted EBITDA margin up 50 bps QoQ; profit versus loss YoY. | Revenue growth, customer demand and profit sustainability. |
Note: The table summarises the supplied updates. Full financial statements, exact reported periods and management commentary should be checked before making an investment decision.
Stocks With Positive Operating Indicators
L&T: Revenue growth of 16% alongside a 27.5% increase in order inflows points to activity across its business pipeline. Investors should assess the quality of new orders, execution timelines, working capital and margins to determine how order growth translates into earnings.
SBI Life and Max Financial Services: The updates highlight insurance business activity. SBI Life's reported 130-basis-point improvement in value of new business (VNB) margin is an important indicator, while Max Financial Services reported 7% growth in annualised premium equivalent (APE). Product mix, persistency and the cost of acquiring new policies remain relevant.
Piramal Pharma and Syngene International: The updates point to improved profitability indicators. Piramal Pharma's reported margin performance and Syngene's margin increase merit attention, but investors should determine whether these improvements arise from recurring operating efficiencies, business mix or other factors.
Indus Towers, LT Foods and Raymond: Their reported EBITDA or margin improvements may be encouraging. The next step is to evaluate the underlying drivers and whether operating performance can be sustained in subsequent quarters.
IndiGo: The September market-share increase is modest, moving from 65% in August to 65.4%. Market share is only one performance indicator; passenger yields, capacity utilisation, fuel costs and operational reliability also influence financial results.
Other Companies Worth Monitoring
United Breweries: Revenue growth of 24% year-on-year and results reported above estimates warrant closer review of sales volumes, realisations and input costs.
PG Electroplast: Product-business growth of 42% year-on-year may indicate strong activity in the reported segment. Capacity utilisation and profitability will help determine the quality of this growth.
Home First Finance: AUM growth of 27% and disbursement growth of 32% highlight expansion in lending activity. Investors should also monitor credit costs, borrowing costs and asset quality.
MedPlus: Revenue growth of 21.3% and a quarter-on-quarter margin increase to 8.3% are worth examining alongside store economics, product mix and operating expenses.
JSW Cement: Reported volumes rose to 3.93 million tonnes from 3.11 million tonnes, while revenue increased 33% year-on-year. Cement realisations and energy costs will be important in evaluating the conversion of growth into profitability.
Tanla Platforms: Revenue growth of 25% and EBITDA growth of 20.8% are positive operating indicators. Investors should assess customer demand, business concentration and whether profit growth remains aligned with revenue growth.
SWOT Analysis: Interpreting the Market Updates
Strengths
Several companies report revenue growth, improved EBITDA margins, stronger order inflows or increased business activity.
Weaknesses
Headline growth may not translate into stronger cash flow or sustainable profits. Some updates lack absolute profit figures or detailed explanations of margin changes.
Quarterly figures should be assessed in context. A high percentage increase may reflect a low base, while a better-than-estimate result may already be reflected in the share price. The operating trend, earnings quality and valuation are all important.
Opportunities
Consistent order growth, improved margins, stronger volumes and healthy lending or insurance growth could support future performance if sustained.
Threats
Input-cost inflation, weaker demand, competition, funding costs, regulatory changes and rich valuations may limit returns even when reported operating indicators improve.
How Traders and Investors Can Use This List
For short-term traders, a corporate update is a catalyst to monitor, not a complete trading signal. The actual market reaction depends on expectations, liquidity, opening price behaviour and broader market conditions.
For longer-term investors, focus on whether the latest results improve the company's earnings outlook and financial strength. Review the complete results, compare year-on-year and quarter-on-quarter trends where relevant, and assess valuation before committing capital.
Valuation and Investment View
The supplied updates identify several companies with encouraging operating indicators, including stronger revenue, EBITDA, margins, order inflows or business volumes. However, the information does not include complete financial statements or current market valuations for every company.
Therefore, this list should be used to prioritise further research rather than to rank stocks by expected return. A company's share price may fall despite strong results if the market had expected even better performance.
For index-market analysis, visit the BankNifty Tip page. Trading decisions should account for individual risk tolerance and market volatility.
Investor Takeaway
Derivative Pro & Nifty Expert Gulshan Khera, CFP®, who is also a SEBI Regd Investment Adviser, observes that the 28 October 2026 watchlist contains a broad mix of earnings, margin and business-growth developments. L&T's order inflows, SBI Life's VNB margin, Piramal Pharma's reported margin performance, Syngene's profitability improvement and IndiGo's market share are among the indicators investors may wish to examine more closely.
These updates do not establish which stock will deliver the best market performance. Investors should verify the full company disclosures, consider valuation and risk, and avoid making decisions based only on headline percentages. For more market analysis, visit Indian-Share-Tips.com or contact 9988877963.
Related Queries on Stocks to Watch and Quarterly Results
1. Which stocks have positive updates on 28 October 2026?
The supplied list includes L&T, SBI Life, Max Financial Services, United Breweries, Piramal Pharma, Syngene, PG Electroplast, Home First Finance, MedPlus, IndiGo, Indus Towers, LT Foods, Raymond, Kirloskar Brothers, Gravita India, Tanla Platforms and others.
2. Why is L&T in focus?
The supplied update reports revenue growth of 16% and order inflow growth of 27.5% year-on-year. Investors can examine order execution, margins and the future order pipeline.
3. What is notable about SBI Life's Q2 update?
The supplied information says Q2 results were in line with estimates and the value of new business margin increased by 130 basis points year-on-year.
4. Why are Piramal Pharma and Syngene worth monitoring?
Piramal Pharma's Q2 results were reported above estimates, with its highest margin since Q4 FY26. Syngene's reported margin was 17.7% versus 12.3%, with net profit versus a quarterly loss.
5. Does revenue or EBITDA growth guarantee a rise in share price?
No. Share-price performance also depends on market expectations, valuation, future guidance, liquidity and broader market conditions.
6. What should investors check before buying a stock after results?
Review the complete financial statements, earnings quality, debt, cash flow, management commentary, valuation and risks. Avoid relying on a single headline metric.
SEBI Disclaimer: This article is for educational and informational purposes only and should not be construed as investment advice or a recommendation to buy or sell any security. The company updates summarised here are based on supplied information and have not been independently verified in this article. Investors should consult official company disclosures, assess their financial circumstances and seek professional advice where appropriate. Investments in securities are subject to market risks. No return is guaranteed.
